AF
ISEE

Amalgamated Financial’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Amalgamated Financial’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$250K Buy
+14,862
New +$220K ﹤0.01% 1811

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amalgamated Financial's ISEE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q1 2022: 14,862 shares worth $250K. The stake represents ﹤0.01% of the portfolio and ranks #1811 among its holdings.

163 funds tracked by Wall St. Rank hold ISEE as of Q1 2022.

  • Amalgamated Financial held 14,862 shares of IVERIC bio, Inc. Common Stock worth $250K as of Q1 2022.
  • IVERIC bio, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • IVERIC bio, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1811 holding.
  • 163 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.